QTTB Stock Price
Q32 Bio Inc.
QTTB stock price is $7.91 (-1.31% on the day), giving Q32 Bio Inc. a market cap of $238.45M. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.
QTTB Stock Overview
- Price
- $7.91
- Previous close
- $8.01
- Open
- $8.01
- Market cap
- $238.45M
- P/E ratio
- 8.0
- 52-week range
- $1.91 - $23.57
- 1-year price target
- $39.60
- Sector
- Healthcare
- Industry
- Biotechnology
- Exchange
- NSC
- MarketXLS Rank
- 44
About Q32 Bio Inc.
Q32 Bio Inc., a clinical-stage biotechnology company, develops biologic therapeutics to restore healthy immune balance in patients with autoimmune and inflammatory diseases driven by pathological immune dysfunction in the United States. The company is developing Bempikibart (ADX-914), a fully human antiinterleukin-7 receptor alpha antagonist monoclonal antibody designed to re-regulate adaptive immune function by blocking signaling mediated by interleukin-7 and thymic stromal lymphopoietin that is Phase 2a clinical trial for the treatment of atopic dermatitis and alopecia areata. Q32 Bio Inc. was formerly known as AdMIRx Inc. and changed its name to Q32 Bio Inc. in April 2020. It is also discovering and developing the ADX-096, a C3d CR1 fusion protein, and other earlier stage assets, including C3d mAb fusions and nanobodies designed for tissue-targeted complement inhibition. The company was founded in 2017 and is based in Waltham, Massachusetts.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | QTTB | $7.91 | -1.3% | 368.94K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |